Affera heart procedure registry study
Part of Heart & circulation clinical trials.
This registry collects information about people who have a heart procedure using the Affera platform. It helps doctors learn more about how well the procedure works in the real world.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old (or the minimum age required in your country).
- You are scheduled to have a procedure using the commercially available Affera platform.
- You are willing and able to follow the study rules and give permission (consent) to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study collects information from people with atrial fibrillation (an irregular heartbeat) who are having a procedure using the PulseSelect PFA system. It helps doctors understand how well this treatment works in real-world settings.
This registry tracks how well the VERAFEYE system works for people having a procedure to treat atrial fibrillation (a type of irregular heartbeat) or to close the left atrial appendage. It helps doctors see if using this imaging tool during the procedure is safe and effective.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This study is a real-world registry that collects health information from people who have atrial fibrillation and were treated with a heart surgery procedure called ablation. It may help doctors better understand outcomes and care for people with this condition.
This study tests a new imaging system (VERAFEYE) that helps doctors guide catheter ablation, a procedure to fix irregular heartbeats like atrial fibrillation. It aims to see if the system makes the procedure safer or more effective.
This study sets up a research “platform” to improve and compare care for people having atrial fibrillation (an irregular heartbeat) treated with ablation. Some patients may be asked for extra imaging or heart-mapping tests during their care, and your eligibility may depend on which extra tests are offered.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.